ENLV Stock Analysis: Buy, Sell, or Hold?
ENLV - Enlivex Therapeutics Ltd. Ordinary Shares
$1.74
-0.10 (-5.71%)
▼
5d:
-12.37%
30d:
-70.29%
90d:
+136.89%
HOLD
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Sep 04, 2026
21d
Get Alerted When ENLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENLV is currently trading at $1.74, which is considered slightly low relative to its 30-day fair value range of $1.43 to $5.38.
Technical Outlook: Technically, ENLV is in a uptrend. Immediate support is located at $1.68, while resistance sits at $2.32. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: ENLV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+4247.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENLV is in a uptrend. Immediate support is located at $1.68, while resistance sits at $2.32. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: ENLV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $80.00 (+4247.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.43 -
$5.38
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading 4247.8% below Wall St target ($80.00)
- CAUTION: Bottoming setup, but lagging the sector by 69% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-12.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.43 -
$5.38
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.68
Resistance Level
$2.32
Current Trend
Uptrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.76
Wall Street Target
$80.00
(+4247.8%)
Share & Embed Analysis
Last updated: August 13, 2026 2:50 PM ET
Data refreshes hourly during market hours. Next update: 3:50 PM
Data refreshes hourly during market hours. Next update: 3:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1086 | 56 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 48 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 29 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
